Skip to Content

AptarGroup Inc - Stock Quote ATR

Rating as of

Morningstar's AptarGroup Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Aptar Starts Year With Strong Q1 Growth; Margin Slightly Down From Mix Shift and Higher Costs

Aaron Degagne Equity Analyst

Analyst Note

| Aaron Degagne |

Narrow-moat Aptar had a good start to the year, with constant-currency sales growth of 13% driven by postpandemic rebounds in the food and beauty segments, though operating margin was about flat year over year. We have slightly reduced our gross margin expectations for the year ahead, offset by higher top-line growth in our model, and our fair value estimate is unchanged at $132 per share. We continue to see the shares as undervalued, trading at a 13% discount to our fair value estimate.

Read Full Analysis

AptarGroup Inc's Company Profile

Business Description

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

265 Exchange Drive, Suite 100
Crystal Lake, IL, 60014
T +1 815 477-0424
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Classic Growth
Employees 13,000